Could McMillan Shakespeare Limited shares be in the buy zone?

McMillan Shakespeare Limited (ASX:MMS) has reported a very strong interim profit result.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in salary packaging service provider McMillan Shakespeare Limited (ASX: MMS) have fallen on Wednesday.

The drop in McMillan Shakespeare's share price is roughly in line with the decline in the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) and the down market would appear to be a more reasonable explanation for McMillan's fall than any specific negative investor reaction to the group's interim financial results which were released after the close of trade on Tuesday.

Here's why…

Revenue leapt 34% to $243.5 million, while underlying net profit after tax but before amortisation of acquisition intangibles jumped 34% to $41.8 million. McMillan can boast of a 10-year compound average growth rate (CAGR) in profits of 22% – an outstanding achievement.

On an underlying earnings per share (EPS) basis, the results were also good, with growth of 22% to 50.6 cents per share (cps). The 10-year CAGR in EPS stands at 19.3%.

Shareholders are set to receive a fully franked interim dividend of 29 cps on April 15, which will represent a 16% increase on the 25 cps received last year.

Turning to valuation, given the growth rates achieved and positive outlook management provided the current pricing of the stock appears compelling.

Based on a consensus forecast for full year EPS of 116.8 cps and dividends totalling 76 cps, the current share price of $11.60 implies a price-to-earnings ratio of just 9.9 times and a fully franked dividend yield of 6.5%. (Source: Thomson Consensus Estimates)

Those metrics certainly seem to be attractive and not only on an absolute basis but also relative to peers SG Fleet Group Ltd (ASX: SGF) and Smartgroup Corporation Ltd (ASX: SIQ) too.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »